Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
Appointed director
|
|
EAGLE PHARMACEUTICALS, INC. (EGRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/30/2018 |
GN
| Analysis: Positioning to Benefit within Dicerna Pharmaceuticals, Sun Life Financial, Autodesk, Eagle Pharmaceuticals, Curis, and Accenture — Research Highlights Growth, Revenue, and Consolidated Results |
| 05/10/2018 |
BW
| Eagle Pharmaceuticals, Inc. Reports First Quarter 2018 Results |
| 05/01/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2018 Financial Results on May 10, 2018 |
| 02/26/2018 |
BW
| Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2017 Results |
| 02/15/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Year End 2017 Financial Results on February 26, 2018 |
| 02/12/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Present at 2018 RBC Capital Markets Global Healthcare Conference |
| 01/02/2018 |
BW
| Eagle Pharmaceuticals, Inc. to Present at 36th Annual J.P. Morgan Healthcare Conference |
| 12/19/2017 |
GN
| Research Report Identifies 2U, AK Steel Holding, American Water Works, Urban Edge Properties, Guidewire Software, and Eagle Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 11/08/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports Third Quarter 2017 Results |
| 10/17/2017 |
BW
| Eagle Pharmaceuticals Announces New Patent for RYANODEX |
| 09/06/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences |
| 08/09/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results |
| 07/31/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss Second Quarter 2017 Financial Results on August 9, 2017 |
| 05/31/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Present at Investor Conferences in June |
| 05/08/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports First Quarter 2017 Results |
| 04/25/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Discuss First Quarter 2017 Financial Results on May 8, 2017 |
| 04/24/2017 |
BW
| Eagle Pharmaceuticals, Inc. to Present at 42nd Annual Deutsche Bank Health Care Conference |
| 03/01/2017 |
BW
| Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2016 Results |
| 02/28/2017 |
BW
| Eagle Pharmaceuticals' Pemetrexed NDA Accepted for Filing by the FDA |
|
|